ImpactU Versión 3.11.2 Última actualización: Interfaz de Usuario: 16/10/2025 Base de Datos: 29/08/2025 Hecho en Colombia
Controlling trapping states on selective theranostic core@shell (NaYF4:Yb,Tm@TiO2-ZrO2) nanocomplexes for enhanced NIR-activated photodynamic therapy against breast cancer cells
ROS production and 801 nm upconversion emission are enhanced by partial substitution of Ti<sup>4+</sup>by Zr<sup>4+</sup>in the NaYF<sub>4</sub>:Yb,Tm@TiO<sub>2</sub>-ZrO<sub>2</sub>–Trastuzumab nanocomplex.
